Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Seagen Inc.
Compass Therapeutics
Tango Therapeutics, Inc.
Travera Inc
Genmab
KaliVir Immunotherapeutics
Beijing Biotech
IDEAYA Biosciences
Vivace Therapeutics, Inc
AstraZeneca
iOnctura
Sotio Biotech Inc.
Endeavor Biomedicines, Inc.
Nuvectis Pharma, Inc.
A2 Biotherapeutics Inc.
A2 Biotherapeutics Inc.
Takeda
Lumicell, Inc.
Perspective Therapeutics
Seagen Inc.
Novartis
Kezar Life Sciences, Inc.
VM Oncology, LLC
Bristol-Myers Squibb
NeoTX Therapeutics Ltd.
HiFiBiO Therapeutics
Ipsen
Incyte Corporation
Actym Therapeutics, Inc.
Merck Sharp & Dohme LLC
Novartis
TCR2 Therapeutics
TCR2 Therapeutics
Incyte Corporation
Incyte Corporation
Merck Sharp & Dohme LLC
A2 Biotherapeutics Inc.
Incyte Corporation
PharmaMar